Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non–Small-Cell Lung Cancer, a Phase II Study of the Hoosier Oncology Group: LUN04-77
Titel:
Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non–Small-Cell Lung Cancer, a Phase II Study of the Hoosier Oncology Group: LUN04-77
Auteur:
Riggs, Heather Jalal, Shadia I. Baghdadi, Tareq Al Bhatia, Sumeet McClean, John Johnson, Cynthia Yu, Menggang Taber, David Harb, Wael Hanna, Nasser